Y
Yingli Wu
H指数:37
被引数:4,347
浏览量:0
个人简介
暂无内容
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
USP2 in cancer: a double-edged sword and therapeutic target
USP2在癌症中:一把双刃剑和 therapeutic target
Identification of YL064 as a novel inhibitor of ATXN3 to suppress tumor growth and metastasis by promoting degradation of oncogenic substrates
YL064作为ATXN3的新型抑制剂,通过促进癌源性底物的降解来抑制肿瘤生长和转移
Cell Death & Disease
IF9.6
TRMT1-mediated tRNA m22G modification drives Osimertinib resistance via the ATXN3/USP25 axis in lung adenocarcinoma
TRMT1介导的tRNA m22G修饰通过ATXN3/USP25轴驱动奥希替尼耐药性在肺腺癌中的作用
Cell Death & Disease
IF9.6
A degradable multi-metal-chelating stealth nanoplatform for dual ferroptosis/cuproptosis-enhanced metalloimmunotherapy in leukemia
一种可降解的多金属螯合的隐形纳米平台,用于在白血病中增强铁死亡/铜死亡的金属免疫疗法
Deubiquitinases in liver diseases: from mechanisms to targeted therapy
去泛素化酶在肝病中的作用:从机制到靶向治疗
USP2 promotes metabolic dysfunction-associated steatotic liver disease progression via stabilization of PPARγ
USP2通过稳定PPARγ促进代谢功能障碍相关脂肪性肝病的进展。
Coinhibition of the MEK/RTK pathway has high therapeutic efficacy in KRAS-mutant non-small cell lung cancer
MEK/RTK通路的协同抑制在KRAS突变型非小细胞肺癌中具有高疗效
Targeting the HuR/E2F7 axis synergizes with bortezomib against multiple myeloma
靶向HuR/E2F7轴与硼替佐米协同作用于多发性骨髓瘤
Multi-omic spatial effects on high-resolution AI-derived retinal thickness
多组学空间效应对高分辨率AI衍生视网膜厚度的影响
NATURE COMMUNICATIONS
IF15.7
Identification of USP2 as a novel target to induce degradation of KRAS in myeloma cells
鉴定USP2作为诱导骨髓瘤细胞中KRAS降解的新型靶点
USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia
USP47稳定YBX1促进急性髓系白血病进展
ONCOGENE
IF7.3
GNF-7, a novel FLT3 inhibitor, overcomes drug resistance for the treatment of FLT3-ITD acute myeloid leukemia
新型FLT3抑制剂GNF-7克服耐药性治疗FLT3-ITD急性髓系白血病

